GlobeNewswire

SolarWinds Cloud Portfolio Enhancements Strengthen Capabilities for Both Infrastructure and Application Monitoring

Dela

Tighter integration and new features empower users to monitor more hosts and more applications, more affordably

AUSTIN, Texas, June  07, 2018  (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced significant enhancements across its SolarWinds Cloud® portfolio of SaaS-based products, including updates to AppOptics(TM), Pingdom®, Papertrail(TM) and Loggly® offerings. These SolarWinds Cloud enhancements have been designed to deepen visibility across both cloud infrastructure and applications to simplify full-stack monitoring for DevOps and IT Ops professionals and enable a more integrated user experience for customers using more than one product.

New Features and Capabilities for AppOptics, Pingdom, Papertrail and Loggly
Specific enhancements that broaden infrastructure and application monitoring support, and enhance simplicity include:

  • AppOptics - Now offers a unified view to quickly identify outliers and usage patterns through new host map and host list view capabilities. Support for seven programming languages, now including Ruby, Go and Node.js®, enables deeper visibility into infrastructure and applications. The AppOptics integration with Papertrail and Loggly makes logs available to provide contextual information for troubleshooting.
  • Pingdom - Now provides up to 13 months of data to deepen digital experience monitoring. In addition, users can now generate shareable online reports to effectively communicate across teams. 
  • Papertrail - Adds a new event viewer, new velocity graphs and dashboard improvements to accelerate troubleshooting.
  • Loggly - Now offers preconfigured dashboards based on log types to simplify monitoring across complex environments. 

"The power of Papertrail is in its simplicity", said Dave North, director of DevOps at Signiant, a US-based media and entertainment company. "The new features build on the product's usability and add real value. For example, being able to favourite groups on the dashboard saves me time. The new velocity graphs are especially valuable as they let us visualise the error rate and quickly determine whether we have a small or large problem."

In addition to these new features, tighter integration within the portfolio can give users the ability to cross-launch among SolarWinds Cloud products. This means that DevOps professionals can now easily move from a dashboard that highlights load time issues on a web page, for example, into a detailed log view to troubleshoot an application infrastructure issue.

"It is too hard and expensive for DevOps and IT Ops professionals to comprehensively monitor the performance of modern applications in their environment", said Christoph Pfister, executive vice president of products, SolarWinds. "The release today extends our comprehensive monitoring capabilities across infrastructure and applications. Using these powerful, affordable products, our customers will see the full picture of traces, metrics, logs and the digital experience, improving the responsiveness of their applications and making their lives much easier."

The SolarWinds Cloud enhancements are the latest milestones in the company's drive to deliver a set of comprehensive, simple and affordable full-stack monitoring solutions. SolarWinds' goal is to enable a single view of infrastructure, applications and digital experience, which will help customers solve their most complex performance and reliability problems quickly, simply and affordably.

Pricing and Availability
The enhanced SolarWinds Cloud offerings are available immediately. Pricing starts at USD 7.50 per month for AppOptics, USD 9.95 per month for Pingdom, USD 7.00 per month for Papertrail and USD 99.00 per month for Loggly.

*Prices as of 4 June 2018 in US dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Connect with SolarWinds

About SolarWinds
SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies and educational institutions. We are committed to focusing exclusively on IT, MSP and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the US Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:  
Nicole Fachet  Jenne Barbour
Text100    SolarWinds
 Phone number: +1 212 871 3950  Phone number: +1 512 498 6804
NicoleF@text100.com pr@solarwinds.com

Images accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/daeb7fcf-3ddf-41c0-97be-238d3044bec0 http://www.globenewswire.com/NewsRoom/AttachmentNg/ee3d687f-4511-48a0-9fd7-3171e56435b6 http://www.globenewswire.com/NewsRoom/AttachmentNg/05156838-17c9-4122-abc3-7bec504e6929 http://www.globenewswire.com/NewsRoom/AttachmentNg/ddce2d73-50d9-4f17-be8d-21ff187c77d5 http://www.globenewswire.com/NewsRoom/AttachmentNg/df7c4694-e876-4a09-b5b0-f24d3d015a37




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum